SARS-CoV-2 进入大脑; COVID-19 的神经表型和纳米生物技术管理
M Kujawska, E Mostafavi, A Kaushik - 中国神经再生研究(英文版), 2023 - sjzsyj.com.cn
… eradicate SARS-CoV-2 (nanomedicine approach for targeted drug … development strategies
modulating SARS-CoV-2 immunity. … management. COVID-19: Coronavirus disease 2019; …
modulating SARS-CoV-2 immunity. … management. COVID-19: Coronavirus disease 2019; …
[PDF][PDF] 新型冠状病毒疫苗研究现状以及仿生纳米疫苗研究前景
左建宏， 黄佳璐， 谢卓熠 - 中南医学科学杂志, 2022 - nhqks.cnjournals.com
… venting novel coronavirus infection (SARS-CoV-2). Different types of vaccines or booster shots
need to be developed to deal with the … SARS-CoV-2: targeted managements and vaccine …
need to be developed to deal with the … SARS-CoV-2: targeted managements and vaccine …
分析傳染性腹膜炎貓隻積液中之貓冠狀病毒及抗體及其與第二型嚴重急性呼吸綜合症冠狀病毒之間的關聯性
甘曜銘 - 2023 - airitilibrary.com
… ) 也具有感受性,當貓同時感染這兩種冠狀病毒,FIPV和SARS-CoV-2之… resulted in uncertainties
in vaccine development. Moreover, cats … This study aimed to increase our knowledge of FIP …
in vaccine development. Moreover, cats … This study aimed to increase our knowledge of FIP …
[HTML][HTML] SARS-CoV-2 入胞机制的研究进展
袁小枚， 李利峰， 王嘉 - Advances in Microbiology, 2023 - hanspub.org
… cellular entry conditions and viral dynamic change during this process helps to understand
the virus-cell interaction and lays fundation for vaccines and therapeutic drugs development. …
the virus-cell interaction and lays fundation for vaccines and therapeutic drugs development. …
[PDF][PDF] PHARMACFU|| CA 菊黨Pharmaceutical Biology
AA Aldathama, R Ahmad, RB Alsaedi… - PHARMACEUTICAL …, 2022 - researchgate.net
… Context: Since the outbreak of SARS-CoV-2, researchers … emphasizes their value in COVlD19
management, such as iota … T cells are not targeted by SARS-CoV-2. The involvement of …
management, such as iota … T cells are not targeted by SARS-CoV-2. The involvement of …
[HTML][HTML] SARS-Cov-2 疫苗接种在贝尔麻痹中的研究进展
余怡， 杜梅， 曾浪， 骆文龙 - Advances in Clinical Medicine, 2023 - hanspub.org
… case fatality rate, SARS-Cov-2 virus has been vigorously invested in vaccine research and
actively promoted large-scale vaccination programs worldwide. Vaccination, as an important …
actively promoted large-scale vaccination programs worldwide. Vaccination, as an important …
2019 冠状病毒病(COVID-19) 概览
Y Shi, G Wang, X Cai, J Deng, L Zheng, H Zhu… - Journal of Zhejiang …, 2020 - Springer
… SARS-CoV-2 is highly contagious and most individuals within the … have focused on
epidemiology, clinical features, diagnosis, management, as well as drug and vaccine development. …
epidemiology, clinical features, diagnosis, management, as well as drug and vaccine development. …
[HTML][HTML] SARS-CoV-2 3CLpro 抑制剂的设计, 合成及分子对接研究
黄云， 司小宝， 何昕玙， 赵慧宇， 亓振凯… - Hans Journal of …, 2022 - hanspub.org
… 开发为新型SARS-CoV-2 3CL pro 抑制剂. Abstract: In this study, SARS-CoV-2 3CL pro inhibitor
… phenyl ester derivatives could be developed as a novel SARS-CoV-2 3CL pro inhibitors. …
… phenyl ester derivatives could be developed as a novel SARS-CoV-2 3CL pro inhibitors. …
COVID-19 疫苗在多发性硬化症患者中的安全性, 免疫原性, 有效性和可接受性: 叙述性文献综述
F Capone, M Rossi, A Cruciani, F Motolese… - 中国神经再生研究 …, 2023 - sjzsyj.com.cn
… campaign aimed at increasing vaccination coverage among … guidelines, the management
of vaccination schedules in high-… developing an attenuated response to SARS-CoV-2 vaccines…
of vaccination schedules in high-… developing an attenuated response to SARS-CoV-2 vaccines…
新型冠状病毒感染对肿瘤治疗的影响
俞荣， 马欢欢， 邓小博， 马斌， 马晨辉， 宋克薇， 俞阳… - 中国肿瘤临床, 2022 - cjco.cn
… is now generally susceptible to SARS-CoV-2; however, patients … with SARS-CoV-2 and the
development of more severe … study aimed to determine the biological effects of SARS-CoV-2 …
development of more severe … study aimed to determine the biological effects of SARS-CoV-2 …